T. Rowe Price Investment Management, Inc. Haemonetics Corp Transaction History
T. Rowe Price Investment Management, Inc.
- $151 Billion
- Q1 2025
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Haemonetics Corp stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 2,195,569 shares of HAE stock, worth $167 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
2,195,569
Previous 2,553,814
14.03%
Holding current value
$167 Million
Previous $199 Million
30.03%
% of portfolio
0.09%
Previous 0.12%
Shares
7 transactions
Others Institutions Holding HAE
# of Institutions
354Shares Held
53MCall Options Held
653KPut Options Held
553K-
Black Rock Inc. New York, NY5.96MShares$454 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$388 Million0.01% of portfolio
-
Neuberger Berman Group LLC New York, NY4.35MShares$331 Million0.24% of portfolio
-
Wellington Management Group LLP Boston, MA2.62MShares$200 Million0.03% of portfolio
-
State Street Corp Boston, MA1.92MShares$146 Million0.01% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $3.91B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...